The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies

Hunzelmann, N.N.HunzelmannRiemekasten, G.G.RiemekastenBecker, M.O.M.O.BeckerMoinzadeh, P.P.MoinzadehKreuter, A.A.KreuterMelchers, I.I.MelchersMueller-Ladner, U.U.Mueller-LadnerMeier, F.F.MeierWorm, M.M.WormLee, H.H.LeeHerrgott, I.I.HerrgottPfeiffer, C.C.PfeifferFierlbeck, G.G.FierlbeckHenes, J.J.HenesJuche, A.A.JucheZeidler, G.G.ZeidlerMensing, H.H.MensingGünther, C.C.GüntherSárdy, M.M.SárdyBurkhardt, H.H.BurkhardtKoehm, M.M.KoehmKuhr, K.K.KuhrKrieg, T.T.KriegSunderkötter, C.C.Sunderkötter2022-03-052022-03-052016https://publica.fraunhofer.de/handle/publica/24609910.1111/bjd.14367en616The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodiesjournal article